Affinity Asset Advisors »

Cogent Biosciences shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Cogent Biosciences (COGT) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Cogent Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cogent Biosciences held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cogent Biosciences by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $12M 350k 35.52
2023-03-31 $1.5M 143k 10.79
2022-12-31 $2.2M 193k 11.56
2022-09-30 $2.3M 154k 14.92
2022-06-30 $1.1M 125k 9.02

More positions owned by Affinity Asset Advisors

Spdr Series Trust State Street Spd Put Option (XBI)
Apogee Therapeutics (APGE)
Insmed Com Par $.01 (INSM)
Abivax Sa Sponsored Ads (ABVX)
Ishares Tr Ishares Biotech Call Option (IBB)
Ventyx Biosciences (VTYX)
Xenon Pharmaceuticals (XENE)
Praxis Precision Medicines I Com New (PRAX)
Cytokinetics Com New (CYTK)
Amgen (AMGN)
Spyre Therapeutics Com New (SYRE)
Wave Life Sciences SHS (WVE)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Select Sector Spdr Tr State Street Hea Call Option (XLV)
Roivant Sciences SHS (ROIV)

View all positions for Affinity Asset Advisors

Top funds holding Cogent Biosciences

FMR
Vanguard Group
BlackRock
Deerfield Management Company
Fairmount Funds Management
Kynam Capital Management
Rtw Investments
TCG Crossover Management
State Street Corporation
Geode Capital Management
Henderson Group
Paradigm Biocapital Advisors
Balyasny Asset Management
Vivo Capital
Octagon Capital Advisors

View all funds holding Cogent Biosciences